title: A national framework for cancer surveillance in the United States.
abstract: Enhancements to cancer surveillance systems are needed for meeting increased demands for data and for developing effective program planning, evaluation, and research on cancer prevention and control. Representatives from the American Cancer Society, Centers for Disease Control and Prevention, National Cancer Institute, National Cancer Registrars Association, and North American Association of Central Cancer Registries have worked together on the National Coordinating Council for Cancer Surveillance to develop a national framework for cancer surveillance in the United States. The framework addresses a continuum of disease progression from a healthy state to the end of life and includes primary prevention (factors that increase or decrease cancer occurrence in healthy populations), secondary prevention (screening and diagnosis), and tertiary prevention (factors that affect treatment, survival, quality of life, and palliative care). The framework also addresses cross-cutting information needs, including better data to monitor disparities by measures of socioeconomic status, to assess economic costs and benefits of specific interventions for individuals and for society, and to study the relationship between disease and individual biologic factors, social policies, and the environment. Implementation of the framework will require long-term, extensive coordination and cooperation among these major cancer surveillance organizations.
authors.affiliation: Centers for Disease Control and Prevention, Atlanta, GA 30341, USA. paw1@cdc.gov
authors.forename: Phyllis A
authors.initials: PA
authors.lastname: Wingo
authors.forename: Holly L
authors.initials: HL
authors.lastname: Howe
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Thun
authors.forename: Rachel
authors.initials: R
authors.lastname: Ballard-Barbash
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Ward
authors.forename: Martin L
authors.initials: ML
authors.lastname: Brown
authors.forename: JoAnne
authors.initials: J
authors.lastname: Sylvester
authors.forename: Gilbert H
authors.initials: GH
authors.lastname: Friedell
authors.forename: Linda
authors.initials: L
authors.lastname: Alley
authors.forename: Julia H
authors.initials: JH
authors.lastname: Rowland
authors.forename: Brenda K
authors.initials: BK
authors.lastname: Edwards
mesh_terms: D000570:American Cancer Society; D002487:Centers for Disease Control and Prevention, U.S.; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D018450:Disease Progression; D006801:Humans; D008403:Mass Screening; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D010166:Palliative Care; D011159:Population Surveillance / Q000379:methods*; D011322:Primary Prevention; D011640:Public Policy; D011788:Quality of Life; D012042:Registries; D012923:Social Class; D015996:Survival Rate; D014481:United States / Q000453:epidemiology